Lorazepam Injection · #12 of 35 active shortages by FDA posting duration
Brand: ATIVAN
FDA lists Lorazepam Injection as Active Shortage (Hikma Pharmaceuticals USA, Inc.).
Availability on file: Unavailable
Lorazepam Injection: Active Shortage
Unavailable 11 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Lorazepam Injection
- Manufacturer
- Hikma Pharmaceuticals USA, Inc.
- Dosage Form
- Injection
- Presentation
- Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10)
- Package NDC
- 0641-6002-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Sep 5, 2018
- Last Updated
- Mar 12, 2026
- Therapeutic Category
- Neurology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Unavailable
Full Drug Profile
lorazepam
Side effects, interactions, warnings & more
Nearby, Other Lorazepam Shortage Records
Lorazepam Injection
Fresenius Kabi USA, LLC
Injection
Lorazepam Injection
Hospira, Inc., a Pfizer Company
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
FDA reason on file: Unavailable. General shortage guidance lives on the tracker hub.